Skip to content
Screener

Aligos Therapeutics, Inc. ALGS Q2 2025 earnings

Reported August 6, 2025 · After market close

Revenue$965.0KBeat by $531.7K
EPS-$1.53Beat by $0.82
Revenue estimate$433.3K
EPS estimate-$2.35

Next report

Nov 5, 2026 (in 2 months)
Revenue estimate$4.9M
EPS estimate-$2.44

FAQ

When did Aligos Therapeutics, Inc. report Q2 2025 earnings?
Aligos Therapeutics, Inc. (ALGS) reported Q2 2025 earnings on August 6, 2025 after market close.
What were Aligos Therapeutics, Inc.'s Q2 2025 revenue and EPS?
Aligos Therapeutics, Inc. reported revenue of $965.0K and eps of $-1.53 for Q2 2025.
Did Aligos Therapeutics, Inc. beat estimates in Q2 2025?
Revenue beat the consensus estimate of $433.3K by $531.7K. EPS beat the consensus estimate of $-2.35 by $0.82.
How did Aligos Therapeutics, Inc.'s Q2 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 9.0% from $1.1M a year earlier.
Where can I find Aligos Therapeutics, Inc.'s Q2 2025 SEC filings?
You can read the 8-K earnings release (0001171843-25-005116) and the 10-Q periodic report (0000950170-25-104042) directly on SEC EDGAR. The filing index links above go to sec.gov.